Cancer organizations are urging researchers, oncologists, and other stakeholders to advocate for cancer research.

The FDA updated the ongoing H&C Farms tomato recall to Class I, reflecting a high risk of salmonella infection.

Having a previous SARS-CoV-2 infection provided a gradient of protection against reinfection, especially against severe forms of COVID-19.

Colorado has reported 11 cases, including one 3-case outbreak, in relation to the 1088-case nationwide spread of measles in 2025.

Certain air pollutants were associated with changes in metabolites among postmenopausal women in the US, potentially impacting bone health.

Pediatric patients exhibited high risk for severe avian influenza A/H5N1, suggesting clinical therapeutic and vaccine trials should be prioritized in this population.

The FDA has approved Nucala (mepolizumab) for the add-on maintenance treatment of patients with inadequately controlled eosinophilic COPD.

Vaping persistence rates were lower in adolescents who used oral nicotine products including nicotine pouches.

Maternal vaccination and, to a lesser extent, nirsevimab appear to significantly reduce RSV-related hospitalizations in infants.

Among the 43 evaluable patients treated with sevabertinib, the confirmed objective response rate was 72.1%.

The HHS terminated funding for for Moderna's avian influenza vaccine due to safety concerns with mRNA vaccines.

Emphysema subtypes, identified via CT, may be linked to cardiopulmonary subphenotypes that can help to target cardiac care in early COPD.